Literature DB >> 17262822

Effects of botulinum toxin A on functional outcome during distraction osteogenesis.

Ronke Olabisi1, Thomas M Best, Ray Vanderby, Sarah Petr, Kenneth J Noonan.   

Abstract

Distraction osteogenesis is useful for correcting limb length inequality, deformities, or short stature. Despite success with bone formation, soft tissue maladaptations including muscle and joint contracture may lead to undesirable results. Botulinum toxin A has been useful in treating spasticity in cerebral palsy, and has been used clinically in select cases to allay contracture in distraction osteogenesis. This study examines the toxin's efficacy in preventing distraction-induced loss of muscle strength and range of motion. The left tibias of 15 New Zealand White rabbits were distracted 1.5 mm/day until approximately a 20% gain was achieved. Each treatment group was divided into animals injected with saline or botulinum toxin in either the gastrocnemius or tibialis anterior muscles. A control group of two additional animals underwent no surgical procedure. Strength and range of motion were assessed prior to, and following, the experiment. At the study's end, animals were euthanized and muscles were harvested, when lengths and weights were recorded. All muscles injected with botulinum toxin showed decreased wet weight and persistent weakness upon completion of the study. Range of motion decreased in all distracted animals. When the gastrocnemius was injected, its strength was reduced but the tibialis anterior strength was preserved, and the limb achieved 22% greater dorsiflexion than saline controls (p = 0.016). When the tibialis anterior received the toxin, plantarflexion was increased by 23% (p = 0.049). Botulinum toxin injection prior to limb distraction increases the "post-lengthened" excursion of the injected muscle and this increased length may have a protective effect on its antagonist. In toxin-injected gastrocnemius muscles, the level of equinus contracture is reduced due to length gains in the Achilles tendon while the anterior tibialis maintains its ability to generate torque. Injection of botulinum toxin in the gastrocnemius may minimize equinus contracture and protect the anterior tibialis from damage during human tibial lengthening. Longer follow-up studies are needed to ensure that toxin-induced muscle weakness resolves with time. (c) 2007 Orthopaedic Research Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17262822     DOI: 10.1002/jor.20349

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  4 in total

1.  What risk factors predict usage of gastrocsoleus recession during tibial lengthening?

Authors:  S Robert Rozbruch; Samuel Zonshayn; Saravanaraja Muthusamy; Eugene W Borst; Austin T Fragomen; Joseph T Nguyen
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

2.  Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial.

Authors:  Hoon Park; Soowan Shin; Han Sol Shin; Hyun Woo Kim; Dong Wook Kim; Dong Hoon Lee
Journal:  Clin Orthop Relat Res       Date:  2016-08-09       Impact factor: 4.176

3.  Botulinum toxin a does not decrease calf pain or improve ROM during limb lengthening: a randomized trial.

Authors:  Dong Hoon Lee; Keun Jung Ryu; Dong Eun Shin; Hyun Woo Kim
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

4.  Impaired joint motion and contractures in callus distraction and segment transport: a retrospective data analysis.

Authors:  Lukas Zak; Gerald E Wozasek
Journal:  Wien Klin Wochenschr       Date:  2013-10-22       Impact factor: 1.704

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.